In a propensity-matched study, women who received a primary prevention implantable cardioverter defibrillator had a significant survival advantage, which was similar to that observed among men.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content